Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
2015 · Leukemia · 239 citations
https://doi.org/10.1038/leu.2015.214
G
Gerhard Zugmaier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
238
Papers
15.1K
Citations
55
h-index
115
i10-index
Gerhard Zugmaier is an academic researcher from Philipps University of Marburg. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & CAR-T cell therapy research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 55, co-authored 203 publications.
ORCID: 0000-0001-6879-2671Papers by this author
worksHarnessing T cells to fight cancer with BiTE<sup>®</sup> antibody constructs – past developments and future directions
2016 · Immunological Reviews · 154 citations
https://doi.org/10.1111/imr.12393
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
2017 · Blood Cancer Journal · 137 citations
https://doi.org/10.1038/s41408-017-0023-x
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
2018 · Blood Cancer Journal · 92 citations
https://doi.org/10.1038/s41408-018-0117-0
Blinatumomab treatment of older adults with relapsed/refractory B‐precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
2016 · Cancer · 91 citations
https://doi.org/10.1002/cncr.30031
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours
2007 · British Journal of Cancer · 71 citations
https://doi.org/10.1038/sj.bjc.6604043
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat